Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer new weight loss drugs?

Danish biotechnology company Zealand Pharma said on Thursday it expected to initiate a phase 2b trial with its obesity treatment candidate petrelintide in the fourth quarter of 2024.

LONDON, Nov 7 — Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar ...

Low-income patients' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

Opens in a new tab or window SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their ... "You ...

Ionis Pharmaceuticals announced the acceptance of a New Drug Application for donidalorsen for prophylactic ... Viking Therapeutics reported updated, early-stage study results on its oral obesity drug ...

Adding just five minutes of exercise to your daily routine lowers your blood pressure and might cut your odds for heart ...

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As ...

With a gain of more than 531% over the last 12 months, shares of Viking Therapeutics (NASDAQ: VKTX) are a hot commodity, to ...

Yet exercise can sometimes be deceptive. Years before starting Virta Health, while cofounding the real-estate company Trulia, Inkinen was an elite Ironman triathlete. He was, and still seems to be, at ...

When you need to work with the health care provider you have, here’s how to advocate for yourself, even while wearing a ...